Total family unit Helicobacter pylori eradication and pediatric re-infection rates

Helicobacter. 2004 Aug;9(4):285-8. doi: 10.1111/j.1083-4389.2004.00240.x.

Abstract

Background: Re-infection with Helicobacter pylori is more common in children than adults, and it is generally accepted that the family unit plays a significant role in primary childhood infection. We investigated whether the family unit plays a significant role in pediatric re-infection and if eradication of H. pylori from the entire family reduces the risk of childhood re-infection.

Methods: Fifty families, each with an H. pylori-infected pediatric index case (mean age 9.48 years), were recruited. A 13carbon urea breath test was performed on all family members in the same house as the index case. Each family unit was randomized into a 'family unit treatment' group (all infected family members treated) or an 'index case treatment' group (index case only treated).

Results: At long-term follow-up (mean 62.2 months), there were three re-infected children in the 'index case treatment' group compared with one in the 'family unit treatment' group. The re-infection rate was 2.4% per patient per year in the 'index case treatment' group and 0.7% per patient per year in the 'family unit treatment' group (p = .31).

Conclusions: This study is the first to evaluate the effect of total family unit H. pylori eradication on pediatric re-infection rates and reports the longest period of re-infection follow-up in children. In childhood, re-infection with H. pylori is not significantly reduced by family unit H. pylori eradication.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Amoxicillin / therapeutic use
  • Breath Tests
  • Child
  • Child, Preschool
  • Clarithromycin / therapeutic use
  • Community-Acquired Infections
  • Family Health*
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / epidemiology*
  • Helicobacter pylori / drug effects*
  • Humans
  • Metronidazole / therapeutic use
  • Omeprazole / therapeutic use
  • Organometallic Compounds / therapeutic use
  • Recurrence
  • Urea / analysis

Substances

  • Organometallic Compounds
  • Metronidazole
  • Amoxicillin
  • Urea
  • Clarithromycin
  • bismuth tripotassium dicitrate
  • Omeprazole